APA način citiranja

Catenacci, D. V., Rasco, D., Lee, J., Rha, S. Y., Lee, K., Bang, Y. J., . . . Wainberg, Z. A. (2020). Phase I Escalation and Expansion Study of Bemarituzumab (FPA144) in Patients With Advanced Solid Tumors and FGFR2b-Selected Gastroesophageal Adenocarcinoma. J Clin Oncol.

Čikaški stil citiranja

Catenacci, Daniel V.T., et al. "Phase I Escalation and Expansion Study of Bemarituzumab (FPA144) in Patients With Advanced Solid Tumors and FGFR2b-Selected Gastroesophageal Adenocarcinoma." J Clin Oncol 2020.

MLA način citiranja

Catenacci, Daniel V.T., et al. "Phase I Escalation and Expansion Study of Bemarituzumab (FPA144) in Patients With Advanced Solid Tumors and FGFR2b-Selected Gastroesophageal Adenocarcinoma." J Clin Oncol 2020.